Glaukos Corp.
Glaukos Corp. develops high‑margin ophthalmic solutions—its iStent micro‑bypass stents for glaucoma, iDose TR injectable therapy, and retinal XR platform—sold to surgery centers and hospitals worldwide, positioning it as a leading eye‑care tech player.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Physicians
- Employees: 995
- HQ: Aliso Viejo
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.